**Robust equity market conditions and an active pipeline of S-1 filings are sustaining elevated probabilities for multiple IPOs completing before year-end 2026.** Through mid-September, issuers have priced or are on track to price several deals, including Orion180 Insurance Group (targeting ~$320 million), Holtec Nuclear (~$825 million range), Electra Therapeutics (~$325 million), and American Savings Bank of Hawaii (~$120 million), with additional filings from biotech, financials, and SPACs. Year-to-date activity has already surpassed prior years, with Renaissance Capital tracking over $250 billion raised across dozens of deals by late summer amid Nasdaq gains exceeding 35% YTD. Key catalysts ahead include this week’s expected pricings and any confidential filers accelerating roadshows, while macro factors such as stable Treasury yields and risk-on sentiment continue to support valuation multiples for growth-oriented listings. Trader consensus in related prediction markets reflects high implied probabilities for near-term debuts given the compressed timeline to December 31.

Sep 8 2026

Mistral AI closes €3 billion funding round at €21 billion valuation

Mistral AI completed a €3 billion Series D funding round in September 2026, raising its valuation to approximately €21 billion (~$24 billion). The company confirmed IPO remains a long-term possibility but no immediate plans or filings have been made.

Sep 8 2026

Mistral AI raises €3 billion at €20 billion valuation, plans IPO after 2026

Mistral AI drops to 5%5%

Mistral AI closed a €3 billion funding round in mid-2026 at a €20 billion valuation, nearly doubling its previous valuation. The company confirmed IPO plans but indicated the listing would likely occur after 2026, focusing on scaling and strategic partnerships in the meantime.

Show more